Prescription Drugs Market 2020 Global Industry Analysis, Potential Growth, Key Players, Latest Trends
The global prescription drugs market size is predicted to reach USD 1,562.15 billion by 2026, exhibiting a CAGR of 8.9% during the forecast period. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases and diabetes will spur sales opportunities for the prescription drugs market revenue during the forecast period. The growing cases of orphan diseases will also have a tremendous impact on the prescription drugs market share. Nonetheless, the ongoing clinical trials by leading players for the development of innovative drugs will enable speedy expansion of the market in the foreseeable future, states Fortune Business Insights in a report, titled “Prescription Drugs Market Size, Share & Industry Analysis, By Product Type (Generics, Orphan, and Other Prescription Drugs), By Therapy (Oncology, Anti-diabetics, Vaccines, Sensory Organs, Immunosuppressants, Anticoagulants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026” the market size stood at USD 811.00 billion in 2018.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/prescription-drugs-market-102709
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Key Diseases - by Key Countries – 2018
4.2. Pipeline Analysis
4.3. Key Industry Developments
4.4. Regulatory Scenario - by Key Regions
4.5. New Product Approvals
5. Global Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product Type
5.2.1. Generics
5.2.2. Orphan
5.2.3. Other Prescription Drugs
5.3. Market Analysis, Insights and Forecast – By Therapy
5.3.1. Oncology
5.3.2. Anti-diabetics
5.3.3. Vaccines
5.3.4. Sensory Organs
5.3.5. Immunosuppressants
5.3.6. Anticoagulants
5.3.7. Others
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies & Drug Stores
5.4.3. Online Pharmacies
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Product Type
6.2.1. Generics
6.2.2. Orphan
6.2.3. Other Prescription Drugs
6.3. Market Analysis – By Therapy
6.3.1. Oncology
6.3.2. Anti-diabetics
6.3.3. Vaccines
6.3.4. Sensory Organs
6.3.5. Immunosuppressants
6.3.6. Anticoagulants
6.3.7. Others
6.4. Market Analysis – By Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies & Drug Stores
6.4.3. Online Pharmacies
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Product Type
7.2.1. Generics
7.2.2. Orphan
7.2.3. Other Prescription Drugs
7.3. Market Analysis – By Therapy
7.3.1. Oncology
7.3.2. Anti-diabetics
7.3.3. Vaccines
7.3.4. Sensory Organs
7.3.5. Immunosuppressants
7.3.6. Anticoagulants
7.3.7. Others
7.4. Market Analysis – By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies & Drug Stores
7.4.3. Online Pharmacies
7.5. Market Analysis – By Country/ sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia pacific Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Product Type
8.2.1. Generics
8.2.2. Orphan
8.2.3. Other Prescription Drugs
8.3. Market Analysis – By Therapy
8.3.1. Oncology
8.3.2. Anti-diabetics
8.3.3. Vaccines
8.3.4. Sensory Organs
8.3.5. Immunosuppressants
8.3.6. Anticoagulants
8.3.7. Others
8.4. Market Analysis – By Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies & Drug Stores
8.4.3. Online Pharmacies
8.5. Market Analysis – By Country/ sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Product Type
9.2.1. Generics
9.2.2. Orphan
9.2.3. Other Prescription Drugs
9.3. Market Analysis – By Therapy
9.3.1. Oncology
9.3.2. Anti-diabetics
9.3.3. Vaccines
9.3.4. Sensory Organs
9.3.5. Immunosuppressants
9.3.6. Anticoagulants
9.3.7. Others
9.4. Market Analysis – By Distribution Channel
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies & Drug Stores
9.4.3. Online Pharmacies
9.5. Market Analysis – By Country/ sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America